BG106169A - Трициклени кондензирани хетероциклени съединения,метод за получаването и използването им - Google Patents

Трициклени кондензирани хетероциклени съединения,метод за получаването и използването им Download PDF

Info

Publication number
BG106169A
BG106169A BG106169A BG10616901A BG106169A BG 106169 A BG106169 A BG 106169A BG 106169 A BG106169 A BG 106169A BG 10616901 A BG10616901 A BG 10616901A BG 106169 A BG106169 A BG 106169A
Authority
BG
Bulgaria
Prior art keywords
group
lower alkyl
substituted
max
compound
Prior art date
Application number
BG106169A
Other languages
Bulgarian (bg)
English (en)
Inventor
Shuji Jinno
Takaaki Okita
Naomi Ohtsuka
Shinya Yamashita
Junichiro Hata
Jiro Takeo
Original Assignee
Nippon Suisan Kaisha, Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Suisan Kaisha, Ltd filed Critical Nippon Suisan Kaisha, Ltd
Publication of BG106169A publication Critical patent/BG106169A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/305—Mercury compounds
    • A61K31/31—Mercury compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/14—[b,f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D337/14—[b,f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BG106169A 1999-06-03 2001-12-03 Трициклени кондензирани хетероциклени съединения,метод за получаването и използването им BG106169A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15718199 1999-06-03
PCT/JP2000/003592 WO2000075127A1 (fr) 1999-06-03 2000-06-02 Composes heterocycliques condenses a trois cycles, procede de preparation correspondant et utilisation de tels composes

Publications (1)

Publication Number Publication Date
BG106169A true BG106169A (bg) 2002-05-31

Family

ID=15643970

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106169A BG106169A (bg) 1999-06-03 2001-12-03 Трициклени кондензирани хетероциклени съединения,метод за получаването и използването им

Country Status (22)

Country Link
US (3) US6602898B1 (ko)
EP (1) EP1182200B1 (ko)
JP (1) JP3471778B2 (ko)
KR (1) KR20020016812A (ko)
CN (1) CN1192027C (ko)
AT (1) ATE303376T1 (ko)
AU (1) AU777414B2 (ko)
BG (1) BG106169A (ko)
BR (1) BR0011529A (ko)
CA (1) CA2370013A1 (ko)
CZ (1) CZ20014261A3 (ko)
DE (1) DE60022341T2 (ko)
DK (1) DK1182200T3 (ko)
ES (1) ES2248080T3 (ko)
HU (1) HUP0201203A3 (ko)
IL (1) IL146732A0 (ko)
NO (1) NO20015832L (ko)
NZ (1) NZ515666A (ko)
PL (1) PL352840A1 (ko)
RU (1) RU2211837C2 (ko)
WO (1) WO2000075127A1 (ko)
ZA (1) ZA200109565B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0415320D0 (en) * 2004-07-08 2004-08-11 Astrazeneca Ab Novel compounds
JP5773585B2 (ja) * 2009-06-29 2015-09-02 日東電工株式会社 発光性トリアリール
TWI698430B (zh) * 2015-02-13 2020-07-11 南北兄弟藥業投資有限公司 三環化合物及其在藥物中的應用
TW201808283A (zh) * 2016-08-05 2018-03-16 廣東東陽光藥業有限公司 含氮三環化合物及其在藥物中的應用
CN109862887B (zh) 2016-11-03 2021-09-10 广东东阳光药业有限公司 一种金刚烷胺类化合物的晶型、组合物及其用途
CN110128432B (zh) * 2018-02-02 2021-03-02 广东东阳光药业有限公司 含氮三环化合物及其在药物中的应用
WO2024140868A1 (zh) * 2022-12-30 2024-07-04 广东东阳光药业股份有限公司 三环化合物的晶型及其用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1302590B (ko) 1966-08-03 1970-11-12
US4104280A (en) 1977-02-04 1978-08-01 Syntex (U.S.A.) Inc. Dibenzo [b.f]thiepin and dibenzo[b.f]oxepin derivatives
PT68303A (en) 1977-07-26 1978-08-01 Merck & Co Inc Process for the preparation of dibenzo/b,f/thiepin
JPS54122284A (en) 1978-02-17 1979-09-21 Dainippon Pharmaceut Co Ltd Dibenzb,foxepin derivative
JPS54115388A (en) 1978-03-01 1979-09-07 Nippon Chemiphar Co Ltd Acetic acid derivative and its preparation
US4237160A (en) 1979-11-27 1980-12-02 Merck Sharp & Dohme (I.A.) Corp. 3-Hydroxymethyldibenzo[b,f]thiepins as prostaglandin antagonists
DE3203065A1 (de) 1982-01-30 1983-08-04 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von dibenzoxepinonen
FR2693655B1 (fr) 1992-07-20 1994-10-14 Virbac Vaccin antirabique avirulent.
PT805155E (pt) 1994-09-28 2002-09-30 Nippon Suisan Kaisha Ltd Novo composto heterociclico condensado, anti-oxidante triciclico
ES2160790T3 (es) 1995-02-08 2001-11-16 Novartis Ag 10-aminoalifatil-dibenzo(b,f)oxepinas de accion antineurodegenerativa.
WO1996025927A1 (fr) 1995-02-22 1996-08-29 Nippon Suisan Kaisha, Ltd. Inhibiteur des recepteurs de l'acide glutamique et ameliorant des fonctions cerebrales
EP0885610A4 (en) 1996-01-19 1999-04-21 Nippon Suisan Kaisha Ltd RELAXING SMOOTH MUSCLES OF THE TRACHEA
JPH10204079A (ja) * 1997-01-20 1998-08-04 Nippon Suisan Kaisha Ltd ジベンゾオキセピンおよびジベンゾチエピン誘導体の製造方法
EA002322B1 (ru) * 1997-04-15 2002-04-25 Киова Хакко Когио Ко., Лтд. Трициклические соединения

Also Published As

Publication number Publication date
EP1182200A1 (en) 2002-02-27
US20030220360A1 (en) 2003-11-27
US6700013B2 (en) 2004-03-02
WO2000075127A8 (fr) 2001-03-15
US6602898B1 (en) 2003-08-05
CN1353703A (zh) 2002-06-12
NZ515666A (en) 2003-10-31
DE60022341D1 (de) 2005-10-06
CZ20014261A3 (cs) 2002-06-12
CA2370013A1 (en) 2000-12-14
CN1192027C (zh) 2005-03-09
ZA200109565B (en) 2003-04-11
JP3471778B2 (ja) 2003-12-02
AU777414B2 (en) 2004-10-14
NO20015832L (no) 2002-02-01
HUP0201203A3 (en) 2004-12-28
DK1182200T3 (da) 2005-12-27
IL146732A0 (en) 2002-07-25
WO2000075127A1 (fr) 2000-12-14
HUP0201203A2 (en) 2002-08-28
US7410997B2 (en) 2008-08-12
NO20015832D0 (no) 2001-11-29
RU2211837C2 (ru) 2003-09-10
BR0011529A (pt) 2002-12-17
KR20020016812A (ko) 2002-03-06
DE60022341T2 (de) 2006-06-29
EP1182200A9 (en) 2002-05-22
PL352840A1 (en) 2003-09-08
ES2248080T3 (es) 2006-03-16
US20040127713A1 (en) 2004-07-01
ATE303376T1 (de) 2005-09-15
AU5104400A (en) 2000-12-28
EP1182200B1 (en) 2005-08-31

Similar Documents

Publication Publication Date Title
EP2199295A1 (en) Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
US5190967A (en) Medicaments for treating erectile disorders
JPH09501442A (ja) 免疫抑制剤として有用な炭素環式および複素環式縮合環キノリンカルボン酸
SK285165B6 (sk) Tetrahydropyridoétery, farmaceutický prostriedok s ich obsahom a ich použitie
US20140128331A1 (en) C-glycoside derivatives
BG106169A (bg) Трициклени кондензирани хетероциклени съединения,метод за получаването и използването им
CN113248524B (zh) 一种双吲哚生物碱化合物及其合成方法和用途
JP5747910B2 (ja) ベンゾアゼピン化合物
HU206204B (en) Process for producing benzopyranol derivatives and pharmaceutical compositions comprising same as active ingredient
TW200417367A (en) Antitussive
WO2002042309A1 (fr) Dérivés d'indole et leur utilisation dans des médicaments
CN111303132B (zh) 一种抗癌化合物及其制备方法和应用
JP2004083567A (ja) 三環性縮合複素環化合物、その製造方法および用途
JPS58210089A (ja) ジヒドロフロクロモン
CN111269222B (zh) 一种化合物及其制备方法和应用
SK17322001A3 (sk) Tricyklické fúzované heterocyklické zlúčeniny, spôsob ich prípravy a použitie
US4707476A (en) Treating states of agitation with azatetracyclic compounds
WO2024109917A1 (zh) 一种三唑衍生物及其在医药上的应用
CN118271237A (zh) 取代苯酚衍生物及其用途
JPS58210090A (ja) 抗アテロ−ム性動脈硬化症７−メチルチオメチルフロクロモン
NZ582191A (en) Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome
JP2007230866A (ja) 高尿酸血症治療剤